Tumor Microenvironment in Mixed Neuroendocrine Non-Neuroendocrine Neoplasms: Interaction between Tumors and Immune Cells, and Potential Effects of Neuroendocrine Differentiation on the Tumor Microenvironment

Simple Summary The neuroendocrine differentiation of tumors is considered to influence the tumor microenvironment through the secretion of various hormones or growth factors. However, cases of neuroendocrine and non-neuroendocrine neoplasms are difficult to compare because of the potential differences in systemic and local immune environments. The analysis of mixed neuroendocrine non-neuroendocrine neoplasms, in which neuroendocrine and non-neuroendocrine components are present in the same tumor, could provide important insights into the effects of neuroendocrine differentiation on tumor microenvironments. However, to the best of our knowledge, this has not been reported yet. Here, we compared the status of the tumor tissue microenvironment, including the infiltrating lymphocytes present, in the neuroendocrine and non-neuroendocrine areas of the same tumor. Factors related to neoangiogenesis and the suppression of tumor immune reactions were more abundant in neuroendocrine than in non-neuroendocrine areas. Therefore, neuroendocrine and non-neuroendocrine tumors differ with respect to the characteristics of both tumor cells and the tumor microenvironment. Abstract The tumor microenvironment is considered to play a pivotal role in various human malignancies. Neuroendocrine and non-neuroendocrine neoplasms are considered to have different tumor microenvironments. However, owing to differences in the systemic and/or local immune statuses, tumor microenvironments in different patients may be difficult to compare. Mixed neuroendocrine non-neuroendocrine neoplasms (MiNENs), although rare, could be useful for exploring the effects of neuroendocrine differentiation on the tumor microenvironment, because both neuroendocrine and non-neuroendocrine components are present in the same tumor. Here, we examined 33 cases of histologically confirmed MiNENs and evaluated the influence of neuroendocrine differentiation on the tumor microenvironment by comparing tumor-infiltrating lymphocytes, tumor-associated macrophages, and other relevant factors in the two components the same tumor. The immunoreactivity of those examined above was evaluated quantitatively. The values of vasohibin-1-positive density (p < 0.0001) and immunoreactivity (p < 0.0001) (representing the neoangiogenesis status) were significantly higher in neuroendocrine as compared to non-neuroendocrine areas of the same tumors. In addition, the Foxp3/CD8 (p = 0.0717) and the PD-1/CD8 ratios (p = 0.0176) (representing tumor immunity suppression) tend to increase in neuroendocrine carcinomas. Immunoreactivity of CD163, a marker of M2-like macrophages, was also higher in the neuroendocrine areas. Our findings indicate that neuroendocrine and non-neuroendocrine tumors differ from each other with respect to the characteristics of both tumor cells and the tumor microenvironment.

[1]  X. Tai,et al.  The small intestine epithelium exempts Foxp3+ Tregs from their IL-2 requirement for homeostasis and effector function , 2021, JCI insight.

[2]  M. Velez,et al.  Poorly differentiated neuroendocrine carcinomas of the gastrointestinal tract: A single-institute study of 43 cases. , 2021, Pathology, research and practice.

[3]  M. Hong,et al.  The Prognostic Value of Sex-Determining Region Y-Box 2 and CD8+ Tumor-Infiltrating Lymphocytes in Limited-Stage Small-Cell Lung Cancer , 2021, Oncology.

[4]  J. Capdevila,et al.  Drug Development in Neuroendocrine Tumors: What Is on the Horizon? , 2021, Current Treatment Options in Oncology.

[5]  S. Staff,et al.  Characterization of immunoreactivity with whole-slide imaging and digital analysis in high-grade serous ovarian cancer , 2020, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[6]  H. Kim,et al.  An Organoid Biobank of Neuroendocrine Neoplasms Enables Genotype-Phenotype Mapping , 2020, Cell.

[7]  Kyoung-Mee Kim,et al.  Digital image analysis in pathologist‐selected regions of interest predicts survival more accurately than whole‐slide analysis: a direct comparison study in 153 gastric carcinomas , 2020, The journal of pathology. Clinical research.

[8]  W. Seeger,et al.  Spatial Density and Distribution of Tumor-Associated Macrophages Predict Survival in Non–Small Cell Lung Carcinoma , 2020, Cancer Research.

[9]  Rong Lin,et al.  Do neuroendocrine carcinomas and mixed neuroendocrine–non-neuroendocrine neoplasm of the gastrointestinal tract have the same prognosis? A SEER database analysis of 12,878 cases , 2020, Therapeutic advances in endocrinology and metabolism.

[10]  H. Grabsch,et al.  Computational image analysis of T-cell infiltrates in resectable gastric cancer: association with survival and molecular subtypes. , 2020, Journal of the National Cancer Institute.

[11]  C. Weidong,et al.  Macrophage M1/M2 polarization. , 2020, European journal of pharmacology.

[12]  D. Birnbaum,et al.  Prognostic impact of tumour‐infiltrating lymphocytes and cancer‐associated fibroblasts in patients with pancreatic adenocarcinoma of the body and tail undergoing resection , 2020, The British journal of surgery.

[13]  V. Deschoolmeester,et al.  Biomarker recommendation for PD‐1/PD‐L1 immunotherapy development in pediatric cancer based on digital image analysis of PD‐L1 and immune cells , 2020, The journal of pathology. Clinical research.

[14]  Mohid S. Khan,et al.  Retrospective study on mixed neuroendocrine non-neuroendocrine neoplasms from five European centres , 2019, World journal of gastroenterology.

[15]  C. Piazza,et al.  Prognostic Significance of Peripheral T‐Cell Subsets in Laryngeal Squamous Cell Carcinoma , 2019, Laryngoscope investigative otolaryngology.

[16]  G. Torzilli,et al.  Tumor-Infiltrating Lymphocytes and Macrophages in Intrahepatic Cholangiocellular Carcinoma. Impact on Prognosis after Complete Surgery , 2019, Journal of Gastrointestinal Surgery.

[17]  K. Lillemoe,et al.  Role of Tumor-Associated Macrophages in the Clinical Course of Pancreatic Neuroendocrine Tumors (PanNETs) , 2019, Clinical Cancer Research.

[18]  Petar Noack,et al.  Accuracy of grading pancreatic neuroendocrine neoplasms with Ki‐67 index in fine‐needle aspiration cellblock material , 2018, Cytopathology : official journal of the British Society for Clinical Cytology.

[19]  H. Sasano,et al.  Programmed death-1 ligands and tumor infiltrating T lymphocytes in primary and lymph node metastasis of esophageal cancer patients. , 2018, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[20]  V. Cogliano International Agency for Research on Cancer (IARC) , 2018, The Grants Register 2019.

[21]  F. Hodi,et al.  Characterization of the Neuroendocrine Tumor Immune Microenvironment , 2018, Pancreas.

[22]  M. Kandefer-Szerszeń,et al.  Colon cancer–derived conditioned medium induces differentiation of THP-1 monocytes into a mixed population of M1/M2 cells , 2018, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[23]  Yasufumi Sato,et al.  Expression of vasohibin-1 and -2 predicts poor prognosis among patients with squamous cell carcinoma of the esophagus. , 2018, Oncology letters.

[24]  Johannes Zimmermann,et al.  Measuring multiple parameters of CD8+ tumor-infiltrating lymphocytes in human cancers by image analysis , 2018, Journal of Immunotherapy for Cancer.

[25]  Shouhao Zhou,et al.  Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States , 2017, JAMA oncology.

[26]  Seung‐Mo Hong,et al.  Recent updates on grading and classification of neuroendocrine tumors. , 2017, Annals of diagnostic pathology.

[27]  R. Lloyd,et al.  WHO classification of tumours of endocrine organs , 2017 .

[28]  Jinghong Xu,et al.  Clinicopathological Features and Prognostic Factors of Colorectal Neuroendocrine Neoplasms , 2017, Gastroenterology research and practice.

[29]  L. Paz-Ares,et al.  Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers , 2016, Oncotarget.

[30]  Youn Wha Kim,et al.  Polarized CD163+ tumor-associated macrophages are associated with increased angiogenesis and CXCL12 expression in gastric cancer. , 2016, Clinics and research in hepatology and gastroenterology.

[31]  Zhong-hua Chu,et al.  Neuroendocrine-like cells -derived CXCL10 and CXCL11 induce the infiltration of tumor-associated macrophage leading to the poor prognosis of colorectal cancer , 2016, Oncotarget.

[32]  H. Sorbye,et al.  ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas , 2016, Neuroendocrinology.

[33]  Jin‐Young Jang,et al.  High ratio of programmed cell death protein 1 (PD-1)(+)/CD8(+) tumor-infiltrating lymphocytes identifies a poor prognostic subset of extrahepatic bile duct cancer undergoing surgery plus adjuvant chemoradiotherapy. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[34]  D. Metz,et al.  Consensus on biomarkers for neuroendocrine tumour disease. , 2015, The Lancet. Oncology.

[35]  Xiaoming Hou,et al.  Vasohibin-1 expression detected by immunohistochemistry correlates with prognosis in non-small cell lung cancer , 2014, Medical Oncology.

[36]  Yufeng Cheng,et al.  The clinical significance of tumor-infiltrating neutrophils and neutrophil-to-CD8+ lymphocyte ratio in patients with resectable esophageal squamous cell carcinoma , 2014, Journal of Translational Medicine.

[37]  M. Gonen,et al.  Regulatory T Cell Infiltration Predicts Outcome Following Resection of Colorectal Cancer Liver Metastases , 2013, Annals of Surgical Oncology.

[38]  C. Capella,et al.  Colorectal Poorly Differentiated Neuroendocrine Carcinomas and Mixed Adenoneuroendocrine Carcinomas: Insights Into the Diagnostic Immunophenotype, Assessment of Methylation Profile, and Search for Prognostic Markers , 2012, The American journal of surgical pathology.

[39]  Drew M. Pardoll,et al.  The blockade of immune checkpoints in cancer immunotherapy , 2012, Nature Reviews Cancer.

[40]  F. Sessa,et al.  Mixed Adenoneuroendocrine Carcinomas (MANECs) of the Gastrointestinal Tract: An Update , 2012, Cancers.

[41]  C. Kim,et al.  The ratio of intra‐tumoral regulatory T cells (Foxp3+)/helper T cells (CD4+) is a prognostic factor and associated with recurrence pattern in gastric cardia cancer , 2011, Journal of surgical oncology.

[42]  E. Tartour,et al.  Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy , 2011, Cancer and Metastasis Reviews.

[43]  F. Bosman,et al.  WHO Classification of Tumours of the Digestive System , 2010 .

[44]  Yasuhiro Suzuki,et al.  Vasohibin-1 expression in endothelium of tumor blood vessels regulates angiogenesis. , 2009, The American journal of pathology.

[45]  M. Grimm,et al.  A murine model of appendicitis and the impact of inflammation on appendiceal lymphocyte constituents , 2007, Clinical and experimental immunology.

[46]  Gerd Ritter,et al.  Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[47]  R. DeLellis Pathology and genetics of tumours of endocrine organs , 2004 .

[48]  Stanley R. Hamilton,et al.  Pathology and genetics of tumours of the digestive system , 2000 .

[49]  H Nagura,et al.  CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. , 1998, Cancer research.